Michael Seres & Mark Reisenauer: July 11, 2016

Bringing Bright Ideas to Cancer Care

New Challenge Designed to Inspire Non-Medicine Innovations

Michael-Seres      Mark-Reisenauer

Michael Seres

Founder of 11Health, ePatient-in-Residence at Stanford Medicine X, cancer survivor and entrepreneur

Mark Reisenauer

Cancer caregiver and senior vice president, oncology, Astellas

By 2030, the global cancer burden is expected to grow to 22.2 million cancer cases.[i] Cancer’s increasing prevalence and the need for more therapies and greater accessibility to them is top of mind for many, especially in light of Vice President Joe Biden’s National Cancer Moonshot Initiative.

Yet, improving cancer care is about more than just treatments. Patients today are able to access more resources and tools than ever before to support their cancer experience, but many still have unmet needs.

 

The C3 Prize™ (see-three prize) was created to uncover new tools and resources that can potentially help patients with cancer, their caregivers and loved ones live better today. More specifically, the C3 Prize seeks submissions in four areas where patients living with cancer and the cancer community face daily challenges: navigating the health care system, adhering to complex medical care requirements, coordinating care and surviving life post-treatment.

Astellas Oncology, along with Robert Herjavec, star of ABC’s Emmy Award-winning hit television show Shark Tank, Stanford Medicine X and MATTER, launched the C3 Prize to give patients and caregivers an opportunity to pursue new ideas and solutions that can make a difference in the lives of patients with cancer, their loved ones and those who care for them. Entries will be accepted through August 8, followed by a live pitch for five finalists at Stanford Medicine X to a panel of judges including Robert Herjavec. From there, three winners will be awarded grants totaling $100,000, mentorship from Astellas and membership to healthcare technology incubator MATTER to bring their ideas to life.

On Monday, July 11, Michael Seres, Founder of 11Health and Mark Reisenauer, senior vice president, oncology sales and marketing, Astellas, are available to discuss the C3 Prize, raise awareness about the need to improve cancer care and explain how your listeners can get involved.

More about Michael Seres

Michael Seres was diagnosed at age 12 with the incurable bowel condition, Crohn’s Disease. In late 2011 he became the 11th person to undergo a small bowel transplant in the UK at The Churchill Hospital in Oxford. More recently he is a two-time cancer survivor after having a high-grade B cell lymphoma.

Michael started blogging about his journey in 2011 and has over 100,000 followers. He is the Co-Chair of NHS Digital Services User Council and helped implement the first Skype clinics in the UK. In 2013, Michael founded 11Health, a connected device startup with which he has developed sensor technology for ostomy patients.

In 2015, Michael was announced as the first ePatient-in-Residence at Stanford Medicine X. He is a current Stanford Medicine X Executive Board member and judge for the C3 Prize.

More about Mark Reisenauer

Mark Reisenauer is senior vice president, oncology business unit of Astellas. In this role, he is responsible for commercial activities supporting marketed products, Astellas’ co-promotion partners and commercial planning for early stage oncology development compounds. Mark is a member of the Astellas US Management Committee.

Mark joined Astellas in 2011 as vice president, sales and marketing, oncology, where he led commercial activities supporting oncology products, Tarceva and the launch of Xtandi.

Prior to joining Astellas, Mark served as senior vice president and chief commercial officer of Micromet Inc. (now part of Amgen), where he led investor and public relations, new product planning and commercial launch planning. Previously, Mark held various sales and marketing leadership roles at Abbott, Pharmacia, Bristol-Myers Squibb and AstraZeneca.

Mark experienced firsthand the complexity of navigating cancer care while his father battled head and neck cancer. After losing his father, he has dedicated his energy toward cancer care innovation.

Mark earned a bachelor’s degree in political science from the University of Wisconsin.

Speak Your Mind

*